Screening for upper gastrointestinal cancers with magnetically controlled capsule gastroscopy: a feasibility study

Area of Science:

• Gastroenterology
• Oncology
• Medical Technology

Background:

• Established medical consortium integrating tertiary hospitals and examination centers in China.
• Focus on disease-specific associations for intensive healthcare delivery.

Purpose of the Study:

• Evaluate the feasibility of the Medical Consortium for Screening Upper Gastrointestinal Cancers (MCSC) model.
• Assess the utility of magnetically controlled capsule gastroscopy (MCCG) for upper GI cancer screening.

Main Methods:

• Retrospective analysis of 6627 asymptomatic subjects undergoing MCCG within the MCSC.
• Data collection and analysis of clinical information from health check-ups between March and November 2018.

Main Results:

• MCSC identified 32 upper GI cancers (0.48%) via MCCG, with an early gastric cancer detection rate of 16.67%.
• Prevalence of gastric polyps (15.54%), ulcers (3.76%), and submucosal tumors (3.17%) was documented.
• MCCG procedure and preparation were well-tolerated by participants.

Conclusions:

• The MCSC model is a feasible approach for upper GI cancer screening, particularly in asymptomatic populations.
• Further prospective research with enhanced operational quality control is recommended to validate findings.